(Q52244422)

28 April 2018

title

Long-term course of interferon-treated chronic hepatitis C. (English)

1 reference

28 April 2018

1 reference

13

1 reference

28 April 2018

author name string

Cammà C

1

1 reference

28 April 2018

Di Marco V

2

1 reference

28 April 2018

Lo Iacono O

3

1 reference

28 April 2018

Almasio P

4

1 reference

28 April 2018

Giunta M

5

1 reference

28 April 2018

Fuschi P

6

1 reference

28 April 2018

Vaccaro A

7

1 reference

28 April 2018

Fabiano C

8

1 reference

28 April 2018

Magrin S

9

1 reference

28 April 2018

Di Stefano R

10

1 reference

28 April 2018

Bonura C

11

1 reference

28 April 2018

Pagliaro L

12

1 reference

28 April 2018

publication date

1 April 1998

1 reference

28 April 2018

published in

Journal of Hepatology

1 reference

28 April 2018

volume

28

1 reference

28 April 2018

issue

4

1 reference

28 April 2018

page(s)

531-537

1 reference

28 April 2018

Interferon for non-A, non-B chronic hepatitis

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980274-2

7 January 2021

Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: effects of dose and duration

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980274-2

7 January 2021

Hepatic hepatitis C virus RNA in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980274-2

7 January 2021

Persistent hepatitis C viremia predicts late relapse after sustained response to interferon-alpha in chronic hepatitis C. TriVeneto Viral Hepatitis Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980274-2

7 January 2021

The effect of interferon on the liver in chronic hepatitis C: a quantitative evaluation of histology by meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980274-2

7 January 2021

Long-term mortality after transfusion-associated non-A, non-B hepatitis. The National Heart, Lung, and Blood Institute Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980274-2

7 January 2021

Transfusion-associated chronic hepatitis C: Alpha-n1 interferon for 6 vs. 12 months

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980274-2

7 January 2021

A randomized controlled trial of high-dose maintenance interferon therapy in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980274-2

7 January 2021

Detection of hepatitis C virus by polymerase chain reaction and response to interferon-alpha therapy: relationship to genotypes of hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980274-2

7 January 2021

HCV viraemia is more important than genotype as a predictor of response to interferon in sicily (Southern Italy)

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980274-2

7 January 2021

Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980274-2

7 January 2021

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980274-2

7 January 2021

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980274-2

7 January 2021

Long-term follow-up of patients with chronic hepatitis C treated with α-interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980274-2

7 January 2021

Significance of serum hepatitis C virus RNA levels in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980274-2

7 January 2021

Virological and biochemical responses to interferon-alpha in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980274-2

7 January 2021

Hepatic hepatitis C virus RNA as a predictor of a long-term response to interferon-alpha therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980274-2

7 January 2021

Randomised trial of effects of interferon-alpha on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980274-2

7 January 2021

10.1016/S0168-8278(98)80274-2

Identifiers

DOI

1 reference

28 April 2018

1 reference

28 April 2018